Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4446_Библиотеки_им_академика_М_И_Перельмана
.pdf
8 Otosclerosis
101
Fig. 8.13 Right ear otosclerosis with the persistent stape-
dial artery (PSA). The posterior half of the footplate is
visible (asterisk) and could be exceptionally accessible for
fenestration
2. Dizziness or vertigo: it can be due to labyrinthitis, which is self-limited and resolves
within 3–6days [39]. Other factors can cause
dizziness like the heating effect of laser, long
prosthesis, and depressed footplate fragment
[40]. Long-lasting dizziness requires exploration to rule out a perilymph stula.
3. Sensorineural hearing loss: less than 1% in
experienced hands [41]. It can be caused by
perilymph stula, granuloma formation, or
very long prosthesis that penetrates deep into
the vestibule (Fig.8.14).
4. Perilymph stula: primary perilymph stula
occurs just after the fenestration and persists
long after, while secondary perilymph stula
appears after a period of time of successful
sealing. The latter is usually due to the dislocation of the prosthesis. Perilymph stula
indicates explorative tympanotomy.
5. Reparative granuloma: it is a reactive granulation tissue that occurs after the surgery. It can
invade the vestibule leading to hearing loss,
tinnitus, and dizziness that appear after
7–12days after the surgery. Most of the cases
end in a profound permanent sensorineural
hearing loss (Fig.8.15).
Fig. 8.14 Reformatted CT-Image along the prosthesis
axis: stapes prosthesis laterally in contact with the long
process of incus and the tympanic membrane (empty
arrow), medially the long piston of the stapes prosthesis
penetrates deep into the vestibule (white arrow).
Thickened footplate between the black arrows
Fig. 8.15 Reformatted CT along the prosthesis axis:
hazy condensations around the piston (white arrows) due
to the proliferative inammatory tissue of the granuloma.
Intravestibular tip of the prosthesis: black arrow
6. Facial palsy: an immediate post stapedectomy
facial palsy is usually due to excessive local
anesthesia inltration. Delayed palsy is usually due to reactivation of the VZ virus or
Bell’s palsy.
7. Otitis media: Rare, but can cause sensorineural hearing loss. The patient should be admit-

102
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
ted to the hospital to receive antibiotics and
steroid. Ear packs, if still in the canal, should
be removed.
8.9.5.1 Failure inStapes Surgery
Causes of persistent
conductive hearing loss
1. Malleus ankylosis
2. Round window
otosclerosis
3. Third window
Short prosthesis or
4.
small diameter
prosthesis
5.
Prosthesis abutting
fenestration margin
Causes of recurrent
conductive hearing loss
1.
Resorptive osteitis of the
incus
2. Displacement of the
prosthesis
New bone formation in
3.
the oval window
4.
Obliteration of the round
window by otosclerosis
The most common cause to perform revision stapes surgery is prosthesis displacement followed
by incus erosion.
8.10 Conservative Treatment
ofHearing Loss
inOtosclerosis
1. Hearing aid.
2. BAHA or middle ear implant.
3. Medical treatment: Given in cases of active
otosclerosis. Signs and symptoms like the
presence of Schwartz sign and onset or worsening of tinnitus, vertigo, or hearing loss can
indicate active disease. The options for medical therapy include:
(a) Sodium Fluoride: change the active lesion
to an inactive lesion.
(b) Bisphosphonates: it induces apoptosis in
osteoclasts, reducing toxic enzymes’ production secondary to abnormal bone
metabolism.
Take-Home Messages
• Otosclerosis typically presents with
slowly progressive unilateral or bilateral
deafness, tinnitus, and vertigo may also
occur.
• The hearing loss encountered in these
patients can be conductive, sensorineural, or mixed.
S. Mansour et al.
• In patients with typical clinical features
and uncomplicated conductive hearing
loss, audiometry tests are mandatory to
establish the diagnosis.
• Imaging study is helpful to determine
the disease stages and differential diagnosis, assess associated anatomic abnormalities, and evaluate postoperative
prosthesis status.
References
1. Schuknecht HF, Barber W.Histologic variants in otosclerosis. Laryngoscope. 1985;95:1307–17.
2. Altmann F, Glasgold A, Macduff JP. The incidence
of otosclerosis as related to race and sex. Ann Otol
Rhinol Laryngol. 1967;76:377–92.
3. Cawthorne T. Otosclerosis. J Laryngol Otol.
1955;9:437–56.
4. Precechtel A.Determination of the effect of pregnancy
on the activation of otosclerosis. Acta Otolaryngol.
1967;63:121–7.
5. Zehnder AF, Kristiansen AG, Adams JC, Kujawa SG,
Merchant SN, McKenna MJ.Osteoprotegrin knockout
mouse demonstrate abnormal remodeling of the otic
capsule and progressive hearing loss. Laryngoscope.
2006;116:201.
6. Sørensen MS, Jørgensen MB, Bretlau P.Drift barriers in the postcartilaginous development of the mammalian otic capsule. Eur Arch Otorhinolaryngol.
1992;249:56–61.
7. Mansour S, Nicolas K, Ahmad HH.Round window
otosclerosis: radiologic classication and clinical correlations. Otol Neurotol. 2011;32:384–92.
8. Moumoulidis I, Axon P, Baguley D, Reid E.A review
on the genetics of otosclerosis. Clin Otolaryngol.
2007;32(4):239–47. Review.
9. Niedermeyer HP, Gantumur T, Neubert WJ,
Arnold W. Measles virus and otosclerosis. Adv
Otorhinolaryngol. 2007;65:86–92.
10. Yoo TJ. Etiopathogenesis of otosclerosis: a hypothesis. Ann Otol Rhinol Laryngol. 1984;93:28–33.
11. Cureoglu S, Schachern PA, Ferlito A, Rinaldo A,
Tsuprun V, Paparella MM. Otosclerosis: etiopathogenesis and histopathology. Am J Otolaryngol.
2006;27(5):334–40.
12. Valvassori GE.Imaging of otosclerosis. Otolaryngol
Clin N Am. 1993;26:359–71.
13. Hueb MM, Goycoolea MV, Paparella MM, Oliveira
JA. Otosclerosis: the University of Minnesota temporal bone collection. Otolaryngol Head Neck Surg.
1991;105:396–405.
14. Schuknecht HF, Kirchner JC.Cochlear otosclerosis:
fact or fantasy? Laryngoscope. 1974;84:766–82.
AL GRAWANY

8 Otosclerosis
103
15. van Loon MC, Merkus P, Smit CF, Smits C, Witte
BI, Hensen EF. Stapedotomy in cochlear implant
candidates with far advanced otosclerosis: a systematic review of the literature and meta-analysis. Otol
Neurotol. 2014;35(10):1707–14.
16. Gristwood RE, Venables WN. Otosclerosis and
chronic tinnitus. Ann Otol Rhinol Laryngol.
2003;112:398–403.
17. Sando I, Hemenway WG, Miller DR, Black
FO. Vestibular pathology in otosclerosis temporal bone histopathological report. Laryngoscope.
1974;84:593–605.
18. Paparella MM, Chasin WD.Otosclerosis and vertigo.
J Laryngol Otol. 1966;80:511–9.
19. Hannley MT. Audiologic characteristics of the
patient with otosclerosis. Otolaryngol Clin N Am.
1993;26(3):373–87.
20. Bel J, Causse J, Michaux P, Cézard R, Canut Y, Tapon
J.Mechanical explanation of the on-off effect (diphasic impedance change) in otospongiosis. Audiology.
1976;15(2):128–40.
21. Lagleyre S, Sorrentino T, Calmels MN, Shin YJ,
Escudé B, Deguine O, Fraysse B.Reliability of highresolution CT scan in diagnosis of otosclerosis. Otol
Neurotol. 2009;30(8):1152–9.
22. Révész P, Liktor B, Liktor B, Sziklai I, Gerlinger I,
Karosi T.Comparative analysis of preoperative diagnostic values of HRCT and CBCT in patients with histologically diagnosed otosclerotic stapes footplates.
Eur Arch Otorhinolaryngol. 2016;273(1):63–72.
23. Ariadna M, Cozma S, Murariu O, Radulescu L, Haba
MSC, Vreme RM, Haba D, Iasi/ RO.ECR 2017 diagnostic value of CBCT in otosclerosis. Poster No 2283;
2017.
24. Fisch U. Stapedotomy versus stapedectomy. Otol
Neurotol. 2009;30(8):1166–7.
25. Cremers CW, Beusen JM, Huygen PL. Hearing gain
after stapedotomy, partial platinectomy, or total stapedectomy for otosclerosis. Ann Otol Rhinol Laryngol.
1991;100:959–61.
26. Spandow O, Soderberg O, Bohlin L.Long-term results
in otosclerotic patients operated by stapedectomy and
stapedotomy. Scand Audiol. 2000;29:186–90.
27. Persson P, Harder H, Magnuson B.Hearing results in
otosclerosis surgery after partial stapedectomy, total
stapedectomy and stapedotomy. Acta Otolaryngol.
1997;117:94–9.
28. Fisch U. Stapedectomy versus stapedectomy. Am J
Otol. 1982;4:112–7.
29. Esquivel CR, Mamikoglu B, Wiet RJ. Long-term
results of small fenestra stapedectomy compared
with large fenestra technique. Laryngoscope.
2002;112:1338–41.
30. House HP, Hansen MR, Al Dakhail AAA, House
JW. Stapedectomy versus stapedotomy: comparison
of results with long-term follow-up. Laryngoscope.
2002;112:2046–50.
31. Wegner I, Kamalski DM, Tange RA, Vincent R,
Stegeman I, van der Heijden GJ, Grolman W.Laser
versus conventional fenestration in stapedotomy for
otosclerosis: a systematic review. Laryngoscope.
2014;124(7):1687–93.
32. Yavuz H, Caylakli F, Ozer F, Ozluoglu LN.Reliability
of microdrill stapedotomy: comparison with pick stapedotomy. Otol Neurotol. 2007;28(8):998–1001.
33. Rosowski JJ, Merchant SN.Mechanical and acoustic analysis of middle ear reconstruction. Am J Otol.
1995;16:486–97.
34. Huber AM, Ma F, Felix H, Linder T. Stapes prosthesis attachment: the effect of crimping on sound
transfer in otosclerosis surgery. Laryngoscope.
2003;113:853–8.
35. Gierek T, Witkowska M, Zbrowska-Bielska D,
Klimczak-Gołab L. Analysis of results of stapedotomy in patients with obliterative otosclerosis.
Otolaryngol Pol. 2006;60(3):377–83.
36. Vincent R, Sperling NM, Oates J, Jindal M.Surgical
ndings and long-term hearing results in 3050
Stapedotomies for primary otosclerosis: a prospective
study with the otology-neurotology database. Otol
Neurotol. 2006;27:S25–47.
37. Gersdorff M, Nouwen J, Gilain C, Decat M,
Betsch C. Tinnitus and otsclerosis. Eur Arch
Otorhinolaryngol. 2000;257:314–6.
38. Berling Holm K, Knutsson J, Strömbäck K,
Danckwardt Lillieström N, Papatziamos G,
Rosenblad A, Von Unge M. Taste disturbance after
stapes surgery: an evaluation of frequency, severity, duration, and quality-of-life. Acta Otolaryngol.
2017;137(1):39–43.
39. Birch L, Elbrond O.Stapedectomy and vertigo. Clin
Otolaryngol. 1985;10:217–23.
40. Mansour S, Magnan J, Haidar H, etal. Comprehensive
and clinical anatomy of the middle ear. Berlin:
Springer; 2013. p.49–81.
41. Glasscock ME III, Storper IS, Haynes DS, Bohrer
PS. Twenty-ve years of experience with stapedectomy. Laryngoscope. 1995;105:899–904.

Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
AbdulsalamAl-Qahtani, ZaidAltamimi,
andReniK.Chandran
9
9.1 Introduction
Hearing loss present at birth (congenital hearing
loss) is categorized according to the underlying
pathology to hereditary (syndromic or nonsyndromic), non-hereditary, and idiopathic. Three
types of hearing loss can be induced depending on
the site of the lesion: conductive, sensorineural, or
a combination of both (mixed) [1].
9.2 Neonatal Hearing Screening
Newborn hearing screening programs show that
the incidence of congenital hearing loss is 2–4
children per 1000 births, and it is considered as
the most frequently occurring birth defect in the
US [2, 3]. Mutations in GJB2 account for 50%
A. Al-Qahtani (*)
Hamad Medical Corporation, Doha, Qatar
Otology Clinical Fellow, Hamad Medical
Corporation, Doha, Qatar
e-mail: aalqahtani@hamad.qa
Z. Altamimi
Otology Clinical Fellow, Hamad Medical
Corporation, Doha, Qatar
e-mail:
Zaltamimi@hamad.qa
R. K. Chandran
Audiology, Hamad Medical Corporation, Doha, Qatar
e-mail: RChandran1@hamad.qa
of people with severe-to-profound congenital
autosomal- recessive non-syndromic hearing
loss [4].
Neonatal hearing screening programs are
available for the early detection of this condition. More than 50% of cases of permanent
hearing impairment in childhood can be
detected shortly after birth [5]. Using the 1-3-6
model intends to screen all newborns within
the first month of birth for early diagnosis and
subsequent early management with a better
developmental outcome [6]. View the algorithm below to check the steps of the screening. However, passing the neonatal screening
does not rule out hearing impairment in childhood. Progressive or late-onset hearing loss
can be undetected by neonatal screening programs [6].
© Springer Nature Switzerland AG 2021
A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_9
AL GRAWANY
105

106
A. Al-Qahtani et al.
Neonatal screening
Pass
No Risk Factors
Discharge The Patient
Genetic
testing
Positive Risk Factors
Re-assessment 1 to 4
weeks
Pass
Evaluate for TORCH
infections
Fail
Confirmed Hearing Loss
9.3 Evaluation ofaChild
withCongenital Hearing
Loss
The general approach to evaluating the child with
suspected congenital hearing loss includes the
following:
• History: pregnancy history, perinatal and
postnatal period, NICU admission, postnatal
infection, ototoxic medications, co-existing
medical conditions, family history of hearing
loss in rst- and second-degree relatives, consanguinity, and ethnic origin.
• Physical examination: a full head and neck
examination should be performed to including any dysmorphic features, the shape, and
position of the external ears, neck examina-
Fail
Re-assessment 1 to 4 weeks
Pass
Audiology re-assessment
Imaging
studies
Fail
Normal Hearing
Screening other
anomalies
tion for cysts, sinuses, and scars (branchiooto-renal syndrome), swelling of the thyroid
gland (may indicate Pendred syndrome), and
unusual pigmentation of the hair, skin, or
eyes (which may indicate an auditory pigmentary disorder).
• Investigation: the following should be con-
sidered: genetic testing, CT/MRI imaging,
thyroid function tests, cardiology evaluation
(Echo and ECG, for possible association with
Jervell and Lange-Nielsen syndrome or congenital heart conditions), or ophthalmology
assessment (electroretinogram if suspected
Usher syndrome).
Risk factors for permanent congenital,
delayed, or progressive hearing loss in childhood
are described in Box 9.1 [5].

9 Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Box 9.1 Risk Factors for Permanent
Congenital, Delayed or Progressive Hearing
Loss in Childhood
• Hearing, speech, language, or developmental
delay
•
Family history of hearing loss
Neonatal intensive care unit stay >5days or
•
receiving any of the following treatments:
extra corporal membrane oxygenation,
assisted ventilation, ototoxic drugs (e.g.,
gentamycin and tobramycin), loop diuretics,
or exchange transfusion for
hyperbilirubinemia
• In utero infections (toxoplasmosis, rubella,
cytomegalovirus, herpes simplex, or syphilis)
•
Craniofacial anomalies, including ear tags, ear
pits, and anomalies that involve the outer ear,
external auditory canal, and temporal bone
Physical ndings associated with a syndrome
•
known to cause permanent hearing loss (e.g.,,
white forelock)
•
Syndromes associated with congenital hearing
loss or progressive or late-onset hearing loss
Neurodegenerative disorders or sensorimotor
•
neuropathies
•
Conrmed bacterial or viral meningitis
• Head trauma, especially of the basal skull, or
temporal bone fractures that require
hospitalization
Chemotherapy
•
9.4 Categories ofCongenital
Hearing Loss
1. Idiopathic (25%).
2. Hereditary (50%):
• Non-syndromic (70%): more common,
the prex “DFN” to designate nonsyndromic DeaFNess, DFN followed by an
A implies dominant inheritance, whereas B
implies recessive inheritance and X implies
X-linked inheritance. Autosomal recessive
(AR) in (75–80%), GJ2B mutation (autosomal recessive) coding for the protein gap
junction beta 2 (also called connexin 26)
results in impaired Potassium (K+)
exchange. Autosomal dominant (AD) in
(20–25%), X-linked in (2–4%), and mitochondrial in <1% [5].
Syndromic (30%): Divided into AR, AD,
•
and X-linked. The most common syndromic form of hereditary SNHL is Usher
syndrome [7], and other AR syndromes
include Pendred syndrome and Jervell and
Lange–Nielsen Syndrome. The most common AD syndrome is Waardenburg [7], and
others include Treacher–Collins Syndrome
(Fig. 9.1), Branchio-oto-renal Syndrome
(mainly mixed hearing loss),
Neurobromatosis Type 2, and Stickler
Syndrome. X-linked includes Alport’s syndrome. Box
9.2 describes the features of
the most common congenital hereditary
hearing loss syndromes.
3. Non-hereditary (25%)
• Malformations: arrest in normal develop-
ment may result in hearing impairment
depending on the timing and nature of the
developmental insult. About 65% of such
abnormalities are bilateral, and 35% are
unilateral. Malformations include
Membranous (Alexander’s Aplasia,
Scheibe Deformity, and Siebenmann–Bing
Dysplasia) and Osseous and Membranous
(Cochlear Hypoplasia, Mondini, Common
Cavity, Cochlear Aplasia, Michel Aplasia,
and Small Internal Auditory Canal).
Mondini malformation is the most common type of cochlear malformation [1].
– Alexander aplasia is one of the mem-
branous malformations, where cochlear
duct differentiation at the level of the
basal coil is limited with resultant
effects on the organ of Corti and the
ganglion cells. Hearing assessment
shows high-frequency sensorineural
hearing loss with adequate residual
hearing in the low frequencies, and
amplication devices can be used.
– Scheibe aplasia (cochleosaccular dys-
plasia or Pars Inferior dysplasia) is
one of the membranous malformations,
and it is a relatively common cochlear
malformation. Scala media is compromised due to the failure of the organ of
Corti development affecting the tectorial and the Reissner’s membranes. It is
107
AL GRAWANY

108
A. Al-Qahtani et al.
Fig. 9.1 Treacher–Collins syndrome
reported in Jervell and Lange Nielsen,
Usher, and Waardenburg syndromes as
well as in congenital rubella infants.
Amplication devices with rehabilitative intervention are benecial in many
of these children.
– Michel aplasia is one of the osseous
and membranous malformations, where
there is complete agenesis of the
petrous portion of the temporal bone
resulting in absence of normal inner
structures and therefore complete deafness. The developmental arrest occurs
early prior to the end of the third gestational week.
– Mondini deformity is one of the osse-
ous and membranous malformations,
and it is the most common type of
cochlear malformation [1]. The developmental arrest occurs at the sixth week
of gestation. It presents with an incomplete partition of the cochlea where it
contains only about 1.5 turns with only
the basal coil and absence of the apical
modiolus and interscalar septum.
Mondini deformity is associated with
enlarged vestibular aqueduct and dilated
vestibule. It is seen in Pendred,
Waardenburg, Treacher–Collins, and
CHARGE syndromes, and it is also
seen in congenital cytomegalovirus
(CMV) infection.
– Enlarged Vestibular Aqueduct
Syndrome is dened as a vestibular
aqueduct measuring more than 1.5mm
on CT scan. It is thought to be one of
the most common congenital causes of
sensorineural hearing loss. It presents
with early onset bilateral progressive
sensorineural hearing loss. It is associated with Pendred syndrome, vestibular
anomalies, Mondini malformation, and
other cochlear anomalies. Mainstay of
treatment is conservative management,
including avoidance of head trauma and
contact sports.

9 Congenital Hearing Loss
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
109
• TORCH Infections: It includes
Toxoplasmosis, Other (syphilis, varicellazoster, parvovirus B19), Rubella,
Cytomegalovirus (CMV), and Herpes.
– Cytomegalovirus: the most com-
mon cause of congenital viral deafness
[8].
– Mumps: the most common infectious
cause of acquired sensorineural hearing
loss.
• Other perinatal factors: prematurity, low
birth weight, teratogenic drugs, maternal
diabetes, hyperbilirubinemia, and neonatal
sepsis.
Box 9.2 Overview of Congenital Hearing Loss Syndromes
Syndrome Features Comments
Autosomal recessive
Usher syndrome Sensorineural hearing loss, retinitis pigmentosa,
Pendred’s
syndrome
Jervell and
Lange-Nielsen
syndrome
Autosomal dominant
Waardenburg
syndrome
Treacher–Collins
syndrome
Branchio-otorenal (BOR)
syndrome
X-linked
Alport’s
syndrome
and vestibular symptoms
Type 1, profound hearing loss, vestibular
symptoms, and retinitis pigmentosa beginning
in rst decade
Type 2, stable mild to severe hearing loss and
retinitis pigmentosa in rst to second decade
Type 3, progressive hearing loss, variable
vestibular symptoms, and variable onset of
retinitis pigmentosa
Sensorineural hearing loss (severe to profound),
goiter, and abnormality of the bony labyrinth
(Mondini dysplasia or enlarged vestibular
aqueduct)
Profound sensorineural hearing loss with
prolongation of QT interval, syncopal episodes,
and risk of sudden death
Most common type of AD; hair (white forelock
1), eyes (heterochromia iridis)
Type 1, white forelock and dystopia canthorum
Type 2, dystopia absent
Type 3, upper limb defects
Type 4, increased incidence of Hirschsprung’s
disease
Conductive hearing loss, underdevelopment of
facial bones (malar and zygomatic hypoplasia)
with malformed ossicles, microtia, cleft palate;
micrognathia, downward slanting eyes,
coloboma of the eyelid
Hearing loss; preauricular pits; malformed
pinnae; Branchial cysts or stulae; renal
anomalies (structural malformations to
agenesis)
Hematuria with progressive renal failure,
progressive late-onset high-frequency
sensorineural hearing loss; anterior lenticonus
and macular ecks
Commonest cause of deafness with
blindness, early diagnosis of retinitis
pigmentosa possible with
electroretinography, and cochlear
implants effective
Iodine transport defect diagnosed by
perchlorate discharge test in those
homozygous for Pendred’s syndrome
(SLC26A4) and euthyroid goiter
Should have a thorough cardiac
evaluation, carriers also at risk for
sudden death, and treatment effective
Hearing loss caused by defective
migration of pigment cells to stria
vascularis
Results from mutations in 1 of 3
collagen genes expressed in glomerular
basement membrane
AL GRAWANY

110
Take-Home Messages
• The most common prenatal cause of
hearing loss is intrauterine infection
(CMV).
• Mutations in GJB2 account for 50% of
severe-to-profound autosomal-recessive
non-syndromic deafness.
• The goal of newborn testing is to screen
by 1 month of age, diagnose hearing
loss by 3 months of age, and initiate
intervention by 6months of age.
• Screening based on risk factors only
detects 50% of infants with substantial
congenital hearing loss.
References
1. Shibata SB, Eliot Shearer A, Richard JH. Genetic
sensorineural hearing loss, Chap. 148. In: Cummings
otolaryngology: head & neck surgery. 6th ed.
Philadelphia: Elsevier; 2015. p.2285–300.
A. Al-Qahtani et al.
2. Parving A. The need for universal neonatal hearing
screening–some aspects of epidemiology and identication. Acta Paediatr. 1999;88(432):69–72.
3. White KR. The current status of EHDI programs in
the United States. Ment Retard Dev Disabil Res Rev.
2003;9(2):79–88.
4. Smith RJ, Robin NH. Genetic testing for deafness–
GJB2 and SLC26A4 as causes of deafness. J Commun
Disord. 2002;35(4):367–77.
5. Chi DH, Sabo DL.Pediatric audiology and implantable hearing device, Chap. 100. In: Bailey’s head and
neck surgery: otolaryngology. 5th ed. Philadelphia:
Lippincott Williams & Wilkins; 2014. p.1507–22.
6. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl
AL.Language of early- and later-identied children
with hearing loss. Pediatrics. 1998;102:1161–71.
7. Smith RJH, Shearer AE, Hildebrand MS, et al.
Deafness and hereditary hearing loss overview. 1999
Feb 14 [Updated 2014 Jan 9]. In: Pagon RA, Adam
MP, Ardinger HH, et al., editors. GeneReviews®
[Internet]. Seattle, WA: University of Washington,
Seattle; 1993–2017.
8. Fowler KB, Boppana SB.Congenital cytomegalovirus (CMV) infection and hearing decit. J Clin Virol.
2006;35:226.

Sensorineural Hearing Loss (SNHL)
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
AishaLarem, ZaidAltamimi, andAdhamAljariri
10
10.1 Introduction
Hearing loss can be dened as an impairment in
the ability to perceive sound stimulus. It includes
three types: Conductive, Sensorineural, and
Mixed hearing loss. Sensorineural hearing loss
(SNHL) occurs due to defect in the sensory apparatus of the cochlea (sensory), or the peripheral
pathways of conduction of nerve impulses (XIII
CN) to the brain or in the central auditory pathway or cortex (neural).
Knowledge of growth, development, and functional anatomy of the inner ear is important to be
able to identify the pathology and diagnose it.
Membranous labyrinth develops from otic placode from the third week of the gestational age
(GA) and then it becomes otocysts subdivided
into vestibular and cochlear compartments.
Cochlea reaches the shape of adult form at
10weeks and adult size at 20weeks GA.Cochlea
is composed of a 35mm coiled bony tube with 2.5
turns, and it is divided into scala vestibuli, scala
tympani, and scala media. Scala vestibuli and
scala tympani contain perilymph, scala media is
located between scala vestibuli and tympani, and
A. Larem (*) · Z. Altamimi · A. Aljariri
Hamad Medical Corporation, Doha, Qatar
e-mail: alarem@hamad.qa; ZAITamimi@hamad.qa;
AAljariri@hamad.qa
it contains the endolymph. Scala media is bounded
by Reissner’s membrane, basilar membrane, osseous spiral lamina, and stria vascularis in the lateral
wall, and it contains the organ of Corti. Organ of
Corti is the receptor organ for hearing, composed
of outer and inner hair cells, supporting cells, and
the tectorial membrane. Inner and outer hair cells
are differing in morphology and innervation.
Inner hair cells’ neural innervation is by type I
neurons which are predominantly afferent neurons, where 15–20 of these neurons innervate
each inner hair cell. Outer hair cells’ neural synapses are by type II neurons which are predominantly efferent, where each type II neuron
branches to innervate around ten outer hair cells.
Sound transduction is dened as converting sound
vibrations (mechanical energy) into neural
impulse (electrical energy) by the movement of
the basilar membrane with the hair cells against
the tectorial membrane, stimulating generation of
nerve ending impulses in spiral ganglion. The spiral ganglion sends axons into the cochlear nerve.
The cochlear nerve transmits auditory information up a series of nuclei to the auditory cortex
where perception occurs. These nuclei include:
(1) cochlear nucleus, (2) superior olivary nuclei,
(3) lateral lemniscus, (4) inferior colliculus, and
(5) medial geniculate nuclei.
Sensorineural hearing loss (SNHL) is fea-
tured with the following
© Springer Nature Switzerland AG 2021
A. Al-Qahtani et al. (eds.), Textbook of Clinical Otolaryngology,
https://doi.org/10.1007/978-3-030-54088-3_10
AL GRAWANY
111
Соседние файлы в папке Библиотека им академика М.И. Перельмана
